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Sudden cardiac death (SCD) remains a global public health problem, despite the recent 
development of effective antiarrhythmic agents and population-based risk prediction 
algorithms.1,2 High blood pressure or hypertension is an established risk factor for SCD.2,3 
Furthermore, disproportionate increases in systolic blood pressure (SBP) in response to 
acute physical and/or psychological stressors are associated with an increased risk of 
cardiovascular events.4  
SBP during exercise testing provides an index of blood pressure reactivity during daily 
physical activities.5 An exaggerated SBP (ESBP) response to exercise testing is associated 
with an increased risk of cardiovascular mortality in healthy individuals,5,6 with a more 
favorable prognosis in hypertensive patients and those with known or suspected coronary 
artery disease.7 However, it remains unclear whether an ESBP response to maximal 
exercise testing is directly or inversely related to the risk of SCD in men with and without 
a history of cardiovascular disease (CVD). We tested the hypothesis that an ESBP response 
to maximal exercise testing may be associated with contrasting rates of SCD in men with 
and without a history of CVD. 
The sample included participants from an ongoing prospective population-based cohort 
study in eastern Finland (the Kuopio Ischemic Heart Disease Study: KIHD), designed to 
investigate risk factors for CVD and related, long-term health outcomes. The present 
analysis evaluated 2,410 men (aged 42-61 years) who had undergone baseline medical 
examinations between 1984 and 1989, including participants with (n=884) and without 
CVD (n=1,526).  
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Exercise blood pressure was manually determined using a standard cuff/stethoscope 
during progressive exercise testing to volitional fatigue on an electrically braked cycle 
ergometer. The peak SBP, expressed as millimeters of mercury (mmHg), was the highest 
value achieved during the exercise test. Although many studies have employed arbitrary 
thresholds to designate an ESBP at peak exercise, we used the criteria of the American 
Heart Association, that is, SBP ≥210 mmHg.  
SCD was defined as a fatal event that occurred within 1 hour after the onset of 
symptoms or within 24 hours when autopsy data did not reveal a non-cardiac cause of SCD 
or after a fatal cardiac arrest following successful resuscitation from ventricular tachycardia 
and/or ventricular fibrillation. Data on SCDs were obtained from interviews with family 
members, hospital records, death certificates, autopsy reports and medico-legal documents.  
We used Cox proportional hazard models adjusted for age, body mass index, resting 
SBP, cigarette smoking, alcohol intake, low-density lipoprotein cholesterol, high-density 
lipoprotein cholesterol, family history of heart disease, diabetes, and directly measured 
maximal oxygen uptake (cardiorespiratory fitness, CRF) to determine the hazard ratios 
(HRs) and 95% confidence intervals (CIs) of ESBP (SBP ≥210 mmHg) for SCD. Statistical 
significance was set at P<0.05 and analyses were conducted using SPSS version 21.0 
(SPSS, Armonk, NY).   
During a median 25-year follow-up, 226 SCDs occurred. In analysis adjusted for 
several potential confounders, compared with men who had a normal SBP response to 
exercise testing, men with an ESBP did not exhibit an increased risk of SCD in the entire 
cohort (HR 1.16, 95% CI 0.86-1.57). However, an increased risk of SCD was observed 
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with an ESBP in men without a history of CVD (HR 1.73, 95% CI 1.07-2.82), whereas the 
direction of effect was reversed but not significant in men with a history of CVD (HR 0.92, 
95% CI 0.60-1.41) (Table 1). The Kaplan-Meier survival analysis, illustrated in Figure 1, 
demonstrated a differential survival rate of SCD in men with and without a history of CVD 
(P<0.05 for log rank test).   
Because SCD remains a major public health problem, identifying independent and 
additive risk factors may help in the development and validation of prediction models to 
reduce the risk of SCD in the general population.1 We found a differential effect of an ESBP 
on SCD outcomes in men with and without a history of CVD, and this remained after 
adjusting for potential confounding variables, including resting SBP and CRF.  
To our knowledge, this is the first long-term study to report a heightened risk of SCD 
associated with an ESBP response to exercise testing in men without a history of CVD. 
The results were not significant in men with a history of CVD. These findings suggest that 
an ESBP response during exercise testing may need to be interpreted differentially in these 
population groups. We previously reported that an elevated SBP during recovery from 
exercise was related to the risk of SCD in the general population,8 whereas an exaggerated 
SBP response during exercise was associated with a lower risk of SCD in patients with 
known or suspected coronary artery disease.9 However, this was not statistically significant. 
Although the reasons for differing outcomes of an ESBP on the risk of SCD between 
men with and without a history of CVD remain unclear, there are several possible 
explanations. An ESBP response to exercise may contribute to autonomic imbalance and 
endothelial dysfunction, inflammation, arterial stiffening, and the development of future 
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hypertension, all of which are risk factors for SCD in men without a history of CVD.5 
Conversely, populations with a high burden of CVD may not be capable of generating the 
inotropic reserve or myocardial contractility to permit the necessary increases in cardiac 
output and SBP during vigorous exercise.10 In a cohort of 1,586 cardiac men, researchers 
reported a negative correlation between the maximal SBP during treadmill exercise testing 
and the annual rate of SCD.11 The annual rate of SCD decreased from 97.9 per 1,000 men 
to 25.3 and 6.6 per 1,000 men as the range of maximal SBP increased from <140 to 140 to 
199 to ≥200 mmHg, respectively. Cardiomegaly, Q waves on the resting ECG, persistent 
post-exercise ST-depression, 2 or 3 vessel coronary disease, reduced ejection fraction, or 
combinations thereof, were most common in men with the lowest SBP values at maximal 
exercise. Whilst an abnormal exercise blood pressure response (decrease in or failure to 
increase maximal SBP with exercise) may be amenable to treatment following cardiac 
rehabilitation in two thirds of 651 patients with heart failure,12 future studies are needed to 
clarify the exact underlying mechanisms and the factors affecting resolution of the 
differential relation between an ESBP and the risk of SCD in men with and without a 
history of CVD.  
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Table 1. Hazard ratio (HR) and 95% confidence interval (CI) for risk of SCD by ESBP in men with and without a history of 
cardiovascular disease.  
Variables 226 SCD 
N (%) 
Model 1 
HR (95% CI) 
Model 2 
HR (95% CI) 
Full cohort 
 
    
<210mmHg  128 (9.5%) 1 (ref) 1 (ref) 
≥210mmHg 98 (9.2%) 1.09 (0.83-1.43) 1.16 (0.86-1.57) 
Men without a history of CVD    
<210mmHg 32 (4.1%) 1 (ref) 1 (ref) 
≥210mmHg 58 (7.7%) 1.96 (1.23-3.04) 1.73 (1.07-2.82) 
Men with a history of CVD 
 
  
<210mmHg  96 (16.8%) 1 (ref) 1 (ref) 
≥210mmHg 40 (12.8%) 0.77 (0.53-1.13) 0.92 (0.60-1.41) 
CI, confidence interval; CVD, cardiovascular disease; ESBP, exaggerated systolic blood pressure; HR, hazard ratio; SCD, sudden 
cardiac death. Model 1: Adjusted for age, body mass index, smoking, alcohol intake, family history of heart disease, diabetes, and 
(history of CVD when exposed for full cohort). Model 2: model 1 plus resting systolic blood pressure and maximal oxygen uptake. 
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Figure 1. Differential pattern of the Kaplan-Meier survival curves for SCD by ESBP in men with and without a history of 
cardiovascular disease.  
 
Men without a history of cardiovascular disease (P<0.05 for log-
rank test)
 
Men with a history of cardiovascular disease (P<0.05 for log-
rank test)
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